Barclays analyst issues OVERWEIGHT recommendation for AZN on January 6, 2026 06:35PM ET. The previous analyst recommendation was Overweight.AZN was trading at $94.42 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for ARGX on January 6, 2026 06:33PM ET. The previous analyst recommendation was Overweight.ARGX was trading at $805.57 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for MT on January 6, 2026 05:26PM ET. The previous analyst recommendation was Overweight.MT was trading at $47.925 at issue of the analyst recommendation.The...
Barclays analyst issues UNDERWEIGHT recommendation for GSK on January 6, 2026 04:50PM ET. The previous analyst recommendation was Equal-Weight.GSK was trading at $50.52 at issue of the analyst recommendation.The overall...
Jefferies analyst issues BUY recommendation for TEVA on January 6, 2026 12:37PM ET. The previous analyst recommendation was Buy.TEVA was trading at $31 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for BLTE on January 6, 2026 10:00AM ET. BLTE was trading at $159.42 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Morgan Stanley analyst issues OVERWEIGHT recommendation for RTO on January 6, 2026 09:37AM ET. RTO was trading at $30.15 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
RBC Capital analyst issues OUTPERFORM recommendation for DEO on January 6, 2026 09:44AM ET. The previous analyst recommendation was Sector Perform.DEO was trading at $89.55 at issue of the analyst...
Bradesco analyst issues OUTPERFORM recommendation for OMAB on January 5, 2026 10:15PM ET. OMAB was trading at $109.26 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
Bradesco analyst issues NEUTRAL recommendation for PAC on January 5, 2026 10:15PM ET. The previous analyst recommendation was Outperform.PAC was trading at $262.45 at issue of the analyst recommendation.The overall...
